TSE:4527Personal Products
A Look At Rohto Pharmaceutical (TSE:4527) Valuation After Its New Share Buyback Plan
Rohto PharmaceuticalLtd (TSE:4527) has announced a share repurchase program, authorizing the buyback of up to 1,500,000 shares for ¥3,000 million. The initiative is intended to improve capital efficiency and support flexible capital policies.
See our latest analysis for Rohto PharmaceuticalLtd.
At a share price of ¥2,412.0, Rohto PharmaceuticalLtd has a 7 day share price return of 2.14% and a 1 year total shareholder return of 6.88%. The 3 year total shareholder return of 10.34% contrasts...